Mechanisms of bronchopulmonary C-fiber hypersensitivity induced by cationic proteins

Lu Yuan Lee, Qihai Gu

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations

Abstract

Cationic proteins secreted by inflammatory cells infiltrating into the airways are known to cause mucosal injury and bronchial hyperresponsiveness. Although an involvement of bronchopulmonary C-fiber afferents in the cationic protein-induced airway hyperresponsiveness has been suggested, direct electrophysiological evidence has not been established. Accordingly, a series of studies was recently carried out using the single-fiber recording technique to determine the responses of pulmonary C fibers to cationic proteins and to investigate the mechanisms possibly underlying these effects. Intratracheal instillation of either human eosinophil granule-derived cationic proteins or synthetic cationic proteins induced a sporadic but intense stimulatory effect on pulmonary C fibers and greatly enhanced the sensitivities of these afferents to both lung inflation and chemical stimuli in anesthetized rats. These responses developed slowly (latency: 20-40s), reached peak in 2-10 min, then gradually declined. The effects of synthetic cationic proteins sustained for >60 min. When administered by intravenous injection or instilled into a different region of the lung, the same cationic proteins had no effect on the C-fiber endings, even at a higher dose. Furthermore, the stimulatory and sensitizing effects of these proteins were completely nullified when their cationic charges were neutralized with negatively charged heparin before delivery. However, heparin administered 5-10 min after the delivery of cationic proteins was ineffective in reversing the effects. In conclusion, intratracheal instillation of cationic proteins consistently induces intense stimulation and sensitization of pulmonary C fibers, and an interaction between the cationic charges carried by these proteins and the airway mucosa is probably responsible.

Original languageEnglish
Pages (from-to)15-22
Number of pages8
JournalPulmonary Pharmacology and Therapeutics
Volume16
Issue number1
DOIs
StatePublished - Feb 2003

Bibliographical note

Funding Information:
The authors are grateful to Dr You-Shuei Lin and Robert Morton for technical assistance, and to Dr Gerald Gleich and his coworkers at the Mayo Clinic (Rochester, Minnesota) for providing the human eosinophil granule-derived cationic proteins. This study was supported by grants HL58686 and HL67379 from the National Institutes of Health.

Funding

The authors are grateful to Dr You-Shuei Lin and Robert Morton for technical assistance, and to Dr Gerald Gleich and his coworkers at the Mayo Clinic (Rochester, Minnesota) for providing the human eosinophil granule-derived cationic proteins. This study was supported by grants HL58686 and HL67379 from the National Institutes of Health.

FundersFunder number
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)R01HL067379

    Keywords

    • Airway hyperresponsiveness
    • Asthma
    • Eosinophil
    • Mucosal inflammation
    • Pulmonary C fibers

    ASJC Scopus subject areas

    • Pulmonary and Respiratory Medicine
    • Biochemistry, medical
    • Pharmacology (medical)

    Fingerprint

    Dive into the research topics of 'Mechanisms of bronchopulmonary C-fiber hypersensitivity induced by cationic proteins'. Together they form a unique fingerprint.

    Cite this